Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PKB171 in couples with asthenozoospermia
NCT06986031Phase 2Terminated
- Sponsor
- Prokrea BCN
- Start
- May 2017
- Primary completion
- Jan 2019
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pentoxifylline PKB171 gel in asthenozoospermia (3 arms), sponsored by Prokrea BCN. Primary endpoint: Rate of clinical pregnancies with fetal heart beat at 9 months. Started May 2017; status: terminated.
02
Drugs
pentoxifylline PKB171 gel
03
Conditions
asthenozoospermia
Beyond the preview
Go deeper on NCT06986031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06986031.